There are 79 resources available
Ultrarare STS: How do we make progress?
Presenter: Anna Maria Frezza
Session: STS 1
Resources:
Slides
Webcast
Update on STS pathology: WHO, WGS, ICCR and more....
Presenter: Christopher Fletcher
Session: STS 1
Resources:
Slides
Webcast
Is doxorubicin still the standard 1st line therapy for all sarcoma subtypes?
Presenter: Peter Reichardt
Session: STS 1
Resources:
Slides
Webcast
Clinical trials for rare STS: How to learn the most from it
Presenter: Antonia Digklia
Session: STS 1
Resources:
Slides
Webcast
On the use of neoadjuvant chemotherapy: Pro’s
Presenter: Alessandro Gronchi
Session: STS 2
Resources:
Slides
Webcast
On the use of neoadjuvant chemotherapy: Con’s
Presenter: Axel Le Cesne
Session: STS 2
Resources:
Webcast
Bone sarcoma differential diagnosis: Methylation array versus morphology
Presenter: Daniel Baumhoer
Session: Bone tumours
Resources:
Slides
Webcast
Proton therapy for chordoma and chondrosarcoma
Presenter: Beate Timmermann
Session: Bone tumours
Resources:
Slides
Webcast
The management of residual disease after TKIs in GIST
Presenter: Carol Swallow
Session: STS 2
Resources:
Slides
Webcast
The requirements of good surgery for STS, today
Presenter: Sylvie Bonvalot
Session: STS 2
Resources:
Slides
Webcast